Filtros de búsqueda

Lista de obras de Erika Bourguet

Class I HDAC Inhibitors: Potential New Epigenetic Therapeutics for Alcohol Use Disorder (AUD).

artículo científico publicado en 2017

Control of melanoma invasiveness by anticollagenolytic agents: a reappraisal of an old concept

artículo científico publicado en 2009

Design, Synthesis, and Use of MMP-2 Inhibitor-Conjugated Quantum Dots in Functional Biochemical Assays

artículo científico publicado en 2016

Epigenetic mechanisms and alcohol use disorders: a potential therapeutic target

artículo científico publicado en 2017

Inhibition of human leukocyte elastase, plasmin and matrix metalloproteinases by oleic acid and oleoyl-galardin derivative(s)

scientific article published on 10 December 2010

Interest of new alkylsulfonylhydrazide-type compound in the treatment of alcohol use disorders

artículo científico publicado en 2018

Introduction of the 4-(4-bromophenyl)benzenesulfonyl group to hydrazide analogs of Ilomastat leads to potent gelatinase B (MMP-9) inhibitors with improved selectivity

artículo científico publicado en 2008

Neutrophil elastase as a target in lung cancer.

artículo científico

Nonpeptide RGD antagonists: a novel class of mimetics, the 5,8-disubstituted 1-azabicyclo[5.2.0]nonan-2-one lactam.

artículo científico publicado en 2003

Photochemical rearrangement of oxaziridines and nitrones in the hexahydroindole series: a convenient synthetic route to 1-azabicyclo[5.2.0]nonan-2-ones as novel RGD mimetics

artículo científico publicado en 2001

Simultaneous presence of unsaturation and long alkyl chain at P'1 of Ilomastat confers selectivity for gelatinase A (MMP-2) over gelatinase B (MMP-9) inhibition as shown by molecular modelling studies

scientific article published on 06 May 2007

Synthesis and conformational studies of pseudopeptides containing an unsymmetrical triazine scaffold.

artículo científico publicado en 2008

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda